November 19, 2008 - IntraOp Medical Corp. announced its second German order for the Mobetron, which delivers intraoperative electron-beam radiation therapy (IOERT) to cancer patients.
The University Hospital Giessen and Marburg GmbH (Marburg), located in Marburg, Germany will be the second Mobetron installation in Germany. The first is the Strahleninstitut in Cologne.
The Mobetron reportedly enables surgeons and radiation oncologists to target the exact area that requires radiation and to deliver high doses of radiation directly to the affected tissue during the cancer surgery. The mobile, self-shielded linear accelerator can move between operating rooms with ease, avoiding the high cost of building shielded vaults to accommodate traditional linear accelerators. Key patient benefits of IOERT are said to include: lower recurrence rates, increased survival rates, shorter treatment cycles and fewer side effects.
Marburg is a leading hospital for cancer care in Germany, maintaining more than 1,000 beds and conducting nearly 15,000 operations in eighteen operating theatres each year.
Professor Engenhart-Cabilic of the department for Radio-Oncology at Marburg, commented, “We are very excited to bring the Mobetron and IOERT to Marburg. By providing this form of radiation treatment to our cancer patients, we are able to offer them the best in cancer care.”
For more information: www.intraopmedical.com

Related Content

News | Quality Assurance (QA)

October 11, 2021 — To maintain safety in radiation therapy (RT), every machine performance and patient delivery ...

Time October 11, 2021
arrow
News | Radiation Therapy

October 7, 2021 — NANOBIOTIX, a late-stage clinical biotechnology company pioneering physics-based approaches to expand ...

Time October 07, 2021
arrow
Feature | Radiation Therapy | By Dave Fornell

To maintain safety in radiation therapy (RT), every machine performance and patient delivery measurement must be as ...

Time October 05, 2021
arrow
Feature | Radiation Therapy

September 28, 2021 — New research from Washington University School of Medicine in St. Louis suggests that radiation ...

Time September 28, 2021
arrow
News | Radiation Oncology

September 28, 2021 — The global radiotherapy devices market is expected to grow from $5.44 billion in 2020 to $5.848 ...

Time September 28, 2021
arrow
News | Prostate Cancer

September 24, 2021 — Scientists have identified two subtypes of metastatic prostate cancer that respond differently to ...

Time September 24, 2021
arrow
News | Radiation Therapy

September 24, 2021 — The "Global Surface Guided Radiation Therapy (SGRT) Devices Market, By Device Type (Portable v/s ...

Time September 24, 2021
arrow
News | Lung Imaging

September 23, 2021 — The National Cancer Institute announced that Virginia Commonwealth University Massey Cancer Center ...

Time September 23, 2021
arrow
News | Radiation Oncology

September 21, 2021 — The development of new research guidelines for interventional oncology that standardize treatment ...

Time September 21, 2021
arrow
News | Radiation Oncology

September 20, 2021 — The rapid pace of developments in the oncology field, mainly brought by cancer immunotherapy, means ...

Time September 20, 2021
arrow
Subscribe Now